ADAM15 and cancer: Identification of ADAM15 isoform-dependent shed substrates using approaches such as TMT-MS-TAILS33,34, will have significant implications for cancer patients, as well as for advancing our understanding of the role of ADAM15 splicing for cancer biology and progression.